Graham Capital Management, L.P. Nevro Corp Transaction History

Graham Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $373,021 - $508,284	12,364 Added 33.8%	48,945 $1.77 Million
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $1.33 Million - $1.81 Million	36,581 New	36,581 $1.45 Million
Q2 2022 Aug 15, 2022	BUY	$40.85 - $77.67 $818,266 - $1.56 Million	20,031 Added 304.56%	26,608 $1.17 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $147,237 - $226,099	2,456 Added 59.6%	6,577 $475,000
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $334,089 - $499,836	4,121 New	4,121 $334,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.